Navigation Links
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
Date:3/7/2013

, except ADS data and per ADS data)Three Months Ended
December 31,Twelve Months Ended
December 31,20122011%Change20122011%ChangeNet revenues:Laboratory Services103,771

87,503

18.6%382,890

311,638

22.9%Manufacturing Services21,888

21,038

4.0%117,022

95,539

22.5%Total net revenues125,659

108,541

15.8%499,912

407,177

22.8%Cost of revenues:Laboratory Services(60,308)

(51,169)

17.9%(235,148)

(184,882)

27.2%Manufacturing Services(16,587)

(14,809)

12.0%(81,526)

(65,851)

23.8%Total cost of revenues(76,895)

(65,978)

16.5%(316,674)

(250,733)

26.3%Gross profit:Laboratory Services43,463

36,334

19.6%147,742

126,756

16.6%Manufacturing Services5,301

6,229

(14.9%)35,496

29,688

19.6%Total gross profit48,764

42,563

14.6%183,238

156,444

17.1%Operating (expenses)/income:Selling and marketing expenses(4,734)

(3,031)

56.2%(15,335)

(10,271)

49.3%General and administrative expenses(17,950)

(17,114)

4.9%(70,324)

(56,956)

23.5%Research and development expenses(2,499)

(2,206)

13.3%(8,136)

(5,407)

50.5%Impairment charges for goodwill and intangible assets(3,415)

-

-(3,415)

-

-Revaluation of contingent consideration3,391

-

-3,391

-

-Total operating expenses(25,207)

(22,351)

12.8%(93,819)

(72,634)

29.2%Operating income23,557

20,212

16.5%89,419

83,810

6.7%Other income (expenses), net:Other income (expenses), net3,285

5,367

(38.8%)8,548

8,509

0.5%Interest income (expenses), net1,487

'/>"/>
SOURCE Wuxi PharmaTech Co. Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
2. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
3. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
4. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
5. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
6. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
7. WuXi PharmaTech to Manufacture Ibalizumab for TaiMed Biologics
8. WuXi PharmaTech Receives GLP Certificate from SFDA for Suzhou Toxicology Facility
9. WuXi PharmaTech Announces Second-Quarter 2012 Results
10. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
11. WuXi PharmaTech Announces First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... European Commission (the "EC") to extend the deadline for ... by a limited number of days in order to ... Deadline extensions are not uncommon in such in-depth ... authorities to facilitate their review of the pending transaction ...
(Date:11/18/2014)... Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced today that ... 2014 at 9:00 a.m. Eastern Time to discuss the ISIS-FXI ... Society of Hematology Annual Meeting and Exposition.  ... or access the webcast at www.isispharm.com .  A webcast ... same address. ABOUT ISIS PHARMACEUTICALS, INC. ...
(Date:11/18/2014)... 18, 2014  AgeneBio, a pharmaceutical company developing ... restore brain function, today announced that the Company,s ... , PhD, has received the Society for Neuroscience,s ... 35 years, Dr. Gallagher,s research at Johns Hopkins ... Hill has led to advancements in the field ...
Breaking Medicine Technology:Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 3AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 2AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 3
(Date:11/18/2014)... 18, 2014 A+ Secure Packaging, ... nutraceutical, dietary supplements and more, announced today that ... Good Manufacturing Practices (GMP) Registration for dietary supplements ... from NSF International verifies the A+ Secure Packaging ... compliance requirements of its clients by demonstrating the ...
(Date:11/18/2014)... Newport Beach, CA (PRWEB) November 18, 2014 ... settle into new routines, many people look at fall ... the holidays. Dr. Kevin Sadati , Orange County ... at this Newport Beach practice. At the Gallery ... his patients taking advantage of his non-invasive cosmetic surgery ...
(Date:11/18/2014)... Haelle HealthDay Reporter MONDAY, ... experience a severe abusive head trauma before the age of ... new study. In addition, among those who survive ... the study found. Abusive head trauma includes shaken baby ... suffers head injuries, according to background information in the study. ...
(Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. 17, ... not have significant heart-health benefits for older people, new ... than 14,000 Japanese people aged 60 to 85, found ... attacks and strokes between people who took aspirin and ... prevention with daily low-dose aspirin does not reduce the ...
(Date:11/18/2014)... Dennis Thompson HealthDay ... Heart attack and stroke patients can safely take aspirin combined ... blood-thinning combination won,t increase a patient,s risk of early death, ... meeting of the American Heart Association in Chicago. The report ... . Analysis of data from more than a dozen ...
Breaking Medicine News(10 mins):Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 3
... News) -- Many children who,ve lost a sister or brother ... as a result of the experience, new research finds. ... Nursing , researchers from Nationwide Children,s Hospital in Columbus, Ohio, ... a sibling impacted them one year later. Siblings were ...
... New breast cancer screening guidelines for women at ... (Canadian Medical Association Journal) (pre-embargo link only) ... women aged 40-49 and extend the screening interval ... practice, to every 2 to 3 years for ...
... 2011) -- Older adults receiving home health care may be ... their age. In fact, nearly 40 percent of seniors receiving ... least one prescription medication that is considered potentially inappropriate to ... Internal Medicine has revealed. The study,s researchers, led ...
... find the main culprit behind the dry, irritated eyes, ... of the population., It,s called Sjgren,s syndrome, a painful ... 6.5 years to diagnose and is difficult to treat. ... how it develops should improve diagnosis and treatment. , ...
... of Michigan Medical School and MedImmune, the global biologics ... work together on a broad range of projects. ... of the nation,s top medical research institutions together with ... biologic therapies. UMMS and MedImmune scientists will ...
... Institutet have developed a new method for counting molecules. ... DNA molecules is a fundamental task in molecular biology ... in cells. Thus, improved measurement techniques are crucial for ... very difficult to detect small individual molecules in a ...
Cached Medicine News:Health News:Siblings Deeply Affected By Child's Cancer Death 2Health News:New breast cancer screening guidelines released 2Health News:New breast cancer screening guidelines released 3Health News:Older adults in home health care at elevated risk for unsafe meds 2Health News:Researchers search for culprit behind dry eyes, mouths and more 2Health News:Researchers search for culprit behind dry eyes, mouths and more 3Health News:U-M Medical School and MedImmune join forces to accelerate search for new therapies 2Health News:A better way to count molecules discovered 2
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
... Radi invented the guidewire-mounted pressure ... way. PressureWire5 Sensor is the only ... pressure, temperature and flow. With significantly ... serves as your primary guidewire, as ...
... ultrasound and MRI-guided vacuum assisted breast biopsies ... the patented, FDA-cleared ATEC system for a ... method of breast biopsy. Its compassionate care ... trust YOU.,9 Gauge Handpieces: Useful for biopsy ...
Three-spring evacuator kits with silicone drains, 10 in. hole pattern, trocar and Y-connector tubing...
Medicine Products: